JWH-198

HY-111280

ST 198

ST 198 is an orally active D3R antagonist. ST 198 can block the expression of nicotine-induced CPP at doses selective for D3R. ST 198 can be used for the research of neurological disease[1].

Ask for quotation

MBS5778533-5mg

ST-198

1351.62 €

MBS5778533-5x5mg

ST-198

5246.75 €

H-051-55

Betatrophin (139-198) (Human) - Antibody

1057.2 €

H-051-57

Betatrophin (133-198) (Mouse) - Antibody

1057.2 €

MBS8298094-10nmol

hsa-miR-198 miRNA Mimic

522.88 €